Previous close | 49.23 |
Open | 47.12 |
Bid | 44.89 x 100 |
Ask | 45.36 x 100 |
Day's range | 44.98 - 48.49 |
52-week range | 3.69 - 53.82 |
Volume | |
Avg. volume | 382,238 |
Market cap | 1.508B |
Beta (5Y monthly) | -1.54 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Just because a business does not make any money, does not mean that the stock will go down. For example, Soleno...